Novavax, Inc.
NVAX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.52B
Close$
$24.78
139.7% upside
Current Fair Value
139.7% upsideUndervalued by 139.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.52 Billion |
|---|---|
| Enterprise Value | $1.72 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.72 |
| Beta | 2.42 |
| Outstanding Shares | 164,574,000 |
Return
| Return on Equity | 129.90% |
|---|---|
| Return on Assets | -25.92% |
| Return on Invested Capital | -29.16% |
Valuation & Multiples
| P/E Ratio | -6.09 |
|---|---|
| PEG | 4.06 |
| Price to Sales | 5.17 |
| Price to Book Ratio | -5.17 |
| Enterprise Value to Revenue | 4.14 |
| Enterprise Value to EBIT | -9.41 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | -2.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.38
Average shareholder expectationRevenue Estimate
$52.51 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$72.66 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.2184▼ 10.08% |
|---|---|
| Total Calls | 4,824,612▲ 23.41% |
| Total Puts | 5,878,200▲ 13.97% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 73.54%▲ 0.71% |
|---|---|
| Total Invested | $1.27B▲ 32.67% |
| Investors Holding | 297▲ 12.00% |
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck